Featured MM&M Awards Sponsor




The CementBloc is a multichannel health and wellness creative agency based in New York. Our Convergent Branding model brings together multidisciplinary experts—in one integrated team with one P&L—to optimize your message across touchpoints and customer segments over time, building strong, dynamic platforms for brand engagement.

SUBSCRIBE TO MM&M


MM&M 
offers the most relevant news, analysis, opinion, feature stories and special reports to nearly 15,000 marketing executives at pharma companies, agencies and in healthcare media. Click here to subscribe.

THE INTERACTIVE GUIDE


Click here to read the MM&M 2013 Game Changers issue, with a report on trends that are changing the industry and a showcase of companies at the forefront of this transition.

2011/12 Pharmaceutical Marketers Directory


NOW FULLY
SEARCHABLE ONLINE
UPDATED MONTHLY @ ThePMD.com
Over 6,000 new names, and 20,000 business connections. From the industry's trusted resource for over 34 years. Now find what you need even quicker and easier with the searchable online edition.

Get connected today and order your personal copy and free online access!

The MM&M News Brief provides news and features delivered direct to your inbox. To access the full text, simply click the headline.

Latest News

Prolia, Xgeva fall short of analysts' Q3 sales forecasts

Amgen's global sales, up 3% in the third quarter, met analyst estimates, but its new denosumab franchise reflected slower growth than expected.
 

Despite HPV vax ad bonanza, low awareness and slacker docs dog uptake

A little over half of US girls ages 13 to 17 have not gotten even one dose of the HPV vaccine, and among the main reasons are poor awareness and the failure of doctors to recommend vaccination, a study shows.
 



Why is Regional Marketing So Hot? Audience will learn how regional marketing can benefit your brand's position; how to make regional marketing simple and executable; and the value of a district level driver analysis and how this can become the foundation of regional marketing intelligence.

In Brief

Company news: Eli Lilly, Merck, HealthiNation and Pfizer

Eli Lilly said it will withdraw severe sepsis treatment Xigris from all markets following results of a recent study, in which the drug did not show a statistically significant reduction in mortality among patients with septic shock.
 

LATEST FEATURES

Tailor-Made Marketing

Aided by the digital revolution, patient marketing programs get increasingly personal, with more customization aimed at differentiating products and keeping patients on therapy, Matthew Arnold reports
 

Who's Really Putting Patients First?

"Patient-centric" may be the buzz, but who's really inspiring better health choices? Alyson Connor shares findings from the behaviorists at MicroMass Communications
 

Therapeutic Focus: Oncology

Targeted therapies have opened doors to tumor control. As drugmakers aim for more focused patient groups, realistic expectations on pricing and revenue potential are proving elusive, finds Noah Pines
 

Back to the Books

The comeback continues. Professional journal advertising climbed in first-half 2011, driven by new and mature products. Marc Iskowitz on the biggest advertisers and most advertised brands
 

Leading Latuda through the crowd

Mark Iwicki's top priority is driving the success of Latuda, an atypical antipsychotic for adults with schizophrenia.
 




Advertise
For details on how to advertise in MM&M News Brief, please email Doreen Gates

Unsubscribe
To unsubscribe from the MM&M News Brief click here.
To manage your entire MM&M profile login to your account.

You are subscribed as: %%EMAIL%%

To contact Haymarket Media for general questions or unsubscribe problems, please reply to this email.

All MM&M newsletters are sent from the domain "email.mmm-online.com". When configuring e-mail or spam
filter rules, please use this domain name.

Medical Marketing & Media Magazine
114 W. 26th Street 4th Floor
New York N.Y. 10001
Phone: (646) 638-6000
Fax: (646) 638-6150
http://www.mmm-online.com/

© 2013 Haymarket Media Inc.